Description

Sensitivity analyses and publication bias assessment for the curcumin-IBS meta-analysis are presented, testing robustness of the pooled effect estimate.

Figure 7

Chart

Source Paper

A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS).

Journal of clinical medicine (2018)

PMID: 30248988

DOI: 10.3390/jcm7100298

Cite This Figure

![Figure 7: Sensitivity analyses and publication bias assessment for the curcumin-IBS meta-analysis are presented, testing robustness of the pooled effect estimate.]()

> Source: Qin Xiang Ng et al. "A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IB." *Journal of clinical medicine*, 2018. PMID: [30248988](https://pubmed.ncbi.nlm.nih.gov/30248988/)

<figure>
  <img src="" alt="Sensitivity analyses and publication bias assessment for the curcumin-IBS meta-analysis are presented, testing robustness of the pooled effect estimate." />
  <figcaption>Figure 7. Sensitivity analyses and publication bias assessment for the curcumin-IBS meta-analysis are presented, testing robustness of the pooled effect estimate.<br>  Source: Qin Xiang Ng et al. "A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IB." <em>Journal of clinical medicine</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30248988/">30248988</a></figcaption>
</figure>

Related Evidence

Curcumin for Irritable Bowel Syndrome (IBS)

Grade C · 2 studies